First, because GSDME is upregulated along with the EMT process and remains functionally intact, pharmaceutical strategies activating GSDME-dependent pyroptosis present a specific opportunity for targeting human neoplasms with mesenchymal characteristics. This evidence concerns the gene GSDME and neoplasm.